Arrowhead Pharmaceuticals Inc. buy Bank of America Co.
Start price
09.12.25
/
50%
€59.64
Target price
09.12.26
€69.55
Performance (%)
-6.71%
Price
08:43
€55.64
Summary
This prediction is currently active. With a performance of -6.71%, the BUY prediction by Bank_of_America_Co_ is trending in the wrong direction. This prediction currently runs until 09.12.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Arrowhead Pharmaceuticals Inc. | -7.065% | -7.065% |
| iShares Core DAX® | 1.644% | 4.865% |
| iShares Nasdaq 100 | 0.747% | 2.923% |
| iShares Nikkei 225® | 2.442% | 6.212% |
| iShares S&P 500 | 0.618% | 2.843% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its price target raised by analysts at Bank of America Corporation from $62.00 to $81.00. They now have a "buy" rating on the stock.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€47.40
01.12.25
01.12.25
€53.46
01.12.26
01.12.26
17.38%
08:43
08:43
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€28.47
02.01.24
02.01.24
€33.76
02.01.25
02.01.25
-33.26%
03.01.25
03.01.25
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€21.76
04.12.23
04.12.23
€26.71
04.12.24
04.12.24
1.56%
05.12.24
05.12.24